G1 THERAPEUTICS, INC. Deferred Revenue
G1 THERAPEUTICS, INC. had Deferred Revenue of $949.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2024-08-08
- 2024-06-30: Deferred Revenue, Current $949.00K.
- 2024-03-31: Deferred Revenue, Current $396.00K.
- 2023-12-31: Deferred Revenue, Current $620.00K.
- 2023-09-30: Deferred Revenue, Current $686.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2024-06-30 | $949.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $396.00K 10-Q · filed 2024-05-01 |
| 2023-12-31 | $620.00K 10-Q · filed 2024-08-08 |
| 2023-09-30 | $686.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $143.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $505.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $7.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $9.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $10.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $17.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $31.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $26.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $185.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $154.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $237.00K 10-K · filed 2022-02-23 |
| 2020-09-30 | $14.03M 10-Q · filed 2020-11-04 |